| Immune checkpoint inhibitor therapy aggravates T Cell–Driven plaque inflammation in atherosclerosis K Poels, MMT van Leent, C Boutros, H Tissot, S Roy, AE Meerwaldt, ... Cardio Oncology 2 (4), 599-610, 2020 | 91 | 2020 |
| Antibody-mediated inhibition of CTLA4 aggravates atherosclerotic plaque inflammation and progression in hyperlipidemic mice K Poels, MMT van Leent, ME Reiche, PJH Kusters, S Huveneers, ... Cells 9 (9), 1987, 2020 | 55 | 2020 |
| Deficiency of the T cell regulator Casitas B-cell lymphoma-B aggravates atherosclerosis by inducing CD8+ T cell-mediated macrophage death TTP Seijkens, K Poels, S Meiler, CM Van Tiel, PJH Kusters, M Reiche, ... European heart journal 40 (4), 372-382, 2019 | 47 | 2019 |
| Immune checkpoint inhibitor treatment and atherosclerotic cardiovascular disease: an emerging clinical problem K Poels, SIM Neppelenbroek, MJ Kersten, ML Antoni, E Lutgens, ... Journal for Immunotherapy of Cancer 9 (6), 2021 | 39 | 2021 |
| Inhibition of PFKFB3 hampers the progression of atherosclerosis and promotes plaque stability K Poels, JG Schnitzler, F Waissi, JHM Levels, ESG Stroes, MJAP Daemen, ... Frontiers in Cell and Developmental Biology 8, 581641, 2020 | 37 | 2020 |
| Malaria parasite-mediated alteration of macrophage function and increased iron availability predispose to disseminated nontyphoidal Salmonella infection KL Lokken, AR Stull-Lane, K Poels, RM Tsolis Infection and immunity 86 (9), e00301-18, 2018 | 37 | 2018 |
| Short-term regulation of hematopoiesis by lipoprotein (a) results in the production of pro-inflammatory monocytes JG Schnitzler, K Poels, LCA Stiekema, C Yeang, S Tsimikas, J Kroon, ... International journal of cardiology 315, 81-85, 2020 | 17 | 2020 |
| E3 Ubiquitin Ligases as Immunotherapeutic Target in Atherosclerotic Cardiovascular Disease K Poels, WG Vos, E Lutgens, TTP Seijkens Frontiers in Cardiovascular Medicine 7, 106, 2020 | 8 | 2020 |
| Immuno-PET Imaging of Atherosclerotic Plaques with [89Zr]Zr-Anti-CD40 mAb—Proof of Concept K Poels, M Schreurs, M Jansen, DJ Vugts, TTP Seijkens, ... Biology 11 (3), 408, 2022 | 7 | 2022 |
| Adipocytes control haematopoiesis and inflammation through CD40 signaling ME Reiche, K Poels, LA Bosmans, WG Vos, CM Van Tiel, MJJ Gijbels, ... Haematologica, 2020 | 7 | 2020 |
| B1b Cell Homeostasis Is Maintained By Cd40 In Atherosclerosis ME Reiche, O Pattarabajinard, A Upadhye, K Poels, C van Tiel, SG Malin, ... Arteriosclerosis, Thrombosis, and Vascular Biology 41 (Suppl_1), A101-A101, 2021 | 1 | 2021 |
| Immune Checkpoint Inhibitors Aggravate T Cell-mediated Plaque Inflammation in Experimental Atherosclerosis K Poels, M van Leent, M Reiche, T Malinova, S Huveneers, M De Winther, ... Arteriosclerosis, Thrombosis, and Vascular Biology 40 (Suppl_1), A134-A134, 2020 | 1 | 2020 |
| Cardiovascular Oncology: Exploring The Effects Of Immune Checkpoint Inhibitors On Experimental Atherosclerosis K Poels, M den Toom, M Reiche, P Kusters, L Beckers, T Seijkens, ... Atherosclerosis 287, e99, 2019 | 1 | 2019 |
| Immuno-PET Imaging of Atherosclerotic Plaques with [89Zr] Zr-Anti-CD40 mAb—Proof of Concept. Biology 2022, 11, 408 K Poels, M Schreurs, M Jansen, DJ Vugts, TTP Seijkens, G van Dongen, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | | 2022 |
| Spotlight on immune cell manipulations in atherosclerosis K Poels NARCIS, 2021 | | 2021 |
